Since our arrival in Canada in 1972 Boehringer Ingelheim has played a varied and integral role in the health of Canadians. We are committed to finding medical breakthroughs and investing in research, development and medicine for therapies which fulfill unmet medical needs.

Through our participation in medical and pharmaceutical research, both in Canada and worldwide, we have contributed to significant improvements in healthcare and developed innovative and cost-effective medicines.

We have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of our work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson’s disease and HIV/AIDS.

Are you a dermatologist or a family physician?

Enjoy a complimentary e-subscription to SkinTherapyLetter®, a prestigious Dermatology journal indexed with the National Library in Washington.

Subscribe Today!